Skip to main content
-
* HELP ! - Expert help urgently needed. Please email us links on relevant papers.
268633
-
Covid-19: Focus should be on new vaccines rather than boosters, says WHO - BMJ 17.01.22
271563
-
Covid-19: Fourth vaccine doses—who needs them and why? - BMJ 07.01.22
269874
-
Covid-19: Whatever happened to the Novavax vaccine? - BMJ 08.12.21
265301
-
Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds - BMJ 03.12.21
265300
-
Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis - MedRxiv 2021
270356
-
Covid-19: GPs need extra staff and capacity to deliver accelerated booster programme, say leaders - BMJ 02.12.21
265299
-
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentr…
265171
-
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome - Science 01.12.21
264277
-
Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland - Science Direct 13.11.21
263111
-
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet 29.10.21
261587
-
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 - CDC 29.10.21
270602
-
Journal: Covid-19 breakthrough infections in vaccinated health care workers - NEJM 14.10.21
263636
-
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study - BMJ 27.08.21
257823
-
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection - MedRxiv 19.08.21
256172
-
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III) - THe Lancet 01.06.21
247429
-
“Vaccine-Induced Covid-19 Mimicry” Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic e…
245947
-
Scientists zero in on long-sought marker of COVID-vaccine efficacy - nature 21.05.21
245703
-
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women - JAMA 13.05.21
245533
-
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California - HealthAffairs 12.05.21
244861
-
Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years - CDC 11.05.21
247430
-
Vaccination plus Decarceration — Stopping Covid-19 in Jails and Prisons - NEJM 29.04.21
247431
-
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN) - The Lancet 23.04.21
247434
-
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - Lancet 23.04.21
247432
-
Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination - JAMA 23.04.21
247433
-
SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women - JAMA 12.04.21
247435
-
Human rights and fair access to COVID-19 vaccines: the International AIDS Society - Lancet 24.03.21
247436
-
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center - NEJM 23.03.21
247437
-
Covid-19 vaccine shortages: what is the cause and what are the implications? - BMJ 19.03.21
247438
-
Covid-19: What do we know about Sputnik V and other Russian vaccines? - BMJ 19.03.21
247439
-
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study - Lancet 18.03.21
247440
-
Covid-19: Chile joins top five countries in world vaccination league - BMJ 17.03.21
247441
-
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients - JAMA 15.03.21
247442
-
SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans - Research Square 10.03.21
247443
-
Acute Allergic Reactions to mRNA COVID-19 Vaccines - JAMA 08.03.21
244333
-
COVID-19 vaccine response in pregnant and lactating women: a cohort study - BMJ 07.03.21
247444
-
Should spreading anti-vaccine misinformation be criminalised? - BMJ 17.02.21
247445
-
Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19 - Association of Anaesthetists 11.02.21
244357
-
Vaccines are curbing COVID: Data from Israel show drop in infections - nature 05.02.21
247446
-
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis - HealthAffairs 04.02.21
244365
-
Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine - MedRxiv 01.02.21
247447
-
COVID-19 : Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal Attention - Gao 28.01.21
247448
-
Why vaccinating staff and supporting self-isolating people are national emergencies - BMJ 28.01.21
244410
-
Covid-19 vaccination: What’s the evidence for extending the dosing interval? - BMJ 06.01.21
247449
-
Covid-19: Vaccine brands can be mixed in “extremely rare occasions,” says Public Health England - BMJ 04.01.21
247450
-
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination - Harvard Edu 2021
244408
-
** Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - NEJM 31.12.20
247451
-
** Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - NEJM 30.12.20
247452
-
A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152 - medrxiv 11.12.20
247453
-
* Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 - The Lancet 08.12.20
247454
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) - The Lancet 18.11.20
247455
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years - The Lancet 17.11.20
247456
-
Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations - NJEM 16.10.20
247457
-
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152) - NIH 01.10.20
247458
-
The global economic cost of COVID-19 vaccine nationalism - RAND 10/20
247459
-
“When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination - NEJM 08.09.20
247460
-
Immunological considerations for COVID-19 vaccine strategies - Nature Review Immunology 04.09.20
247461
-
India will supply coronavirus vaccines to the world — will its people benefit? - nature 03.09.20
247462
-
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine - NEJM 02.09.20
247463
-
Nationalisme vaccinal à l’ère de la Covid-19 : Un frein à l’endiguement de la pandémie - Policy Center for the New South 02.09.20
268507
-
COVID-19 vaccines and neglected pregnancy - Lancet 27.08.20
247464
-
China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes - nature 31.07.20
247465
-
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques - Nature 20.07.20
247466
-
Development of an inactivated vaccine candidate for SARS-CoV-2 - Science 06.05.20
244700
-
COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges - Lancet 04.05.20
247467
-
Considering BCG vaccination to reduce the impact of COVID-19 - Lancet 30.04.20
244701
-
The race for coronavirus vaccines: a graphical guide - Nature 28.04.20
244703
-
SARS-CoV-2 surrogate virus neutralization test (sVNT) based on antibody-mediated blockage of ACE2-spike (RBD) protein-protein interaction - Nature Research 23.04.20
244704
-
The COVID-19 vaccine development landscape - Nature's Review 09.04.20
244707
-
If a coronavirus vaccine arrives, can the world make enough? - nature 09.04.20
244706
-
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine - PNAS 30.03.20
244710
-
Should scientists infect healthy people with the coronavirus to test vaccines? - nature 26.03.20
244712
-
Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19 - medRxiv 24.03.20
247468
-
Estimating the effect of cooperative versus uncooperative strategies of COVID-19 vaccine allocation: a modeling study - Chinazza, Mu et al
247470
